Making IT Count logo

Virtual Patient: Providing Safe Immunotherapy Treatment

In this patient simulation, you will evaluate and treat a patient with persistent allergies. The decisions you make should be based on safety considerations in allergen immunotherapy treatments, such as Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). Just like in your clinic, you will want to make the correct decisions so that the allergy and asthma treatments you initiate are on target--and keep your patient out of the emergency department. A mentor will provide feedback throughout the simulation.

Making IT Count is funded through an educational grant from Merck & Co., Inc.

Target Audience

  • Allergist/immunologists
  • Fellows-in-Training
  • Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Obtain appropriate historical information to determine appropriate allergy diagnostic evaluation without putting the patient through unnecessary tests or procedures
  2. Utilize results of history and allergy diagnostic information to initiate appropriate allergy and asthma treatment 
  3. Make appropriate clinical decisions during the course of the patient’s immunotherapy treatment
Summary
Available credit: 
  • 0.50 Attendance
    Attendance credit.
  • 0.50 CE
    CE credit.
  • 0.50 CME
    CME credit.
Course opens: 
02/14/2017
Course expires: 
02/11/2020
Cost:
$0.00
Rating: 
0

Christopher W. Calabria, MD FAAAAI
Dilley Allergy and Asthma, San Antonio, TX
Relevant relationships: None

Anna H. Nowak-Wegrzyn, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Relevant relationships: Merck (advisory board); Thermofischer Scientific (speaker)

CME Committee Reviewers
Anne E. Borgmeyer, RN CPNP AE-C
St. Louis Children's Hospital
Relevant relationships: None

Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon
Relevant relationships: None

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.50 Contact Hours.

Medium and Method of Physician Participation 
Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME Info Page.
  3. Complete all required components.
  4. Complete the Commitment to Change form.
  5. Complete the activity evaluation.
  6. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  7. Print or save your certificate.

AAAAI Privacy Policy
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Questions
Activity-related questions should be directed to cme@aaaai.org.

Available Credit

  • 0.50 Attendance
    Attendance credit.
  • 0.50 CE
    CE credit.
  • 0.50 CME
    CME credit.

Accreditation Period

Course opens: 
02/14/2017
Course expires: 
02/11/2020

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.